Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 13 studies | 43% ± 24% | |
glutamatergic neuron | 10 studies | 44% ± 23% | |
oligodendrocyte precursor cell | 9 studies | 42% ± 20% | |
GABAergic neuron | 7 studies | 52% ± 24% | |
oligodendrocyte | 6 studies | 38% ± 18% | |
interneuron | 5 studies | 54% ± 30% | |
neuron | 4 studies | 31% ± 16% | |
endothelial cell | 3 studies | 24% ± 7% | |
granule cell | 3 studies | 43% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 11 studies | 40% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 6079.81 | 2641 / 2642 | 99% | 89.64 | 698 / 705 |
prostate | 60% | 577.83 | 148 / 245 | 67% | 10.25 | 336 / 502 |
ovary | 74% | 969.30 | 133 / 180 | 37% | 4.26 | 160 / 430 |
intestine | 45% | 508.46 | 432 / 966 | 47% | 4.57 | 248 / 527 |
pancreas | 1% | 5.58 | 2 / 328 | 88% | 19.89 | 157 / 178 |
eye | 0% | 0 | 0 / 0 | 81% | 11.45 | 65 / 80 |
skin | 20% | 171.69 | 355 / 1809 | 56% | 20.82 | 264 / 472 |
stomach | 17% | 154.72 | 60 / 359 | 55% | 5.98 | 157 / 286 |
uterus | 42% | 784.52 | 72 / 170 | 27% | 3.96 | 124 / 459 |
bladder | 24% | 248.14 | 5 / 21 | 36% | 3.76 | 183 / 504 |
lung | 2% | 18.88 | 13 / 578 | 54% | 6.34 | 626 / 1155 |
breast | 7% | 58.17 | 30 / 459 | 46% | 5.99 | 511 / 1118 |
esophagus | 16% | 166.16 | 230 / 1445 | 36% | 4.20 | 65 / 183 |
thymus | 1% | 5.95 | 5 / 653 | 42% | 4.11 | 256 / 605 |
blood vessel | 42% | 1021.61 | 565 / 1335 | 0% | 0 | 0 / 0 |
kidney | 1% | 8.13 | 1 / 89 | 35% | 3.84 | 313 / 901 |
liver | 3% | 25.20 | 6 / 226 | 30% | 7.30 | 120 / 406 |
adrenal gland | 2% | 15.15 | 4 / 258 | 30% | 6.11 | 68 / 230 |
tonsil | 0% | 0 | 0 / 0 | 24% | 5.40 | 11 / 45 |
adipose | 6% | 63.92 | 69 / 1204 | 0% | 0 | 0 / 0 |
heart | 2% | 15.67 | 16 / 861 | 0% | 0 | 0 / 0 |
muscle | 1% | 11.84 | 12 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1904753 | Biological process | negative regulation of vascular associated smooth muscle cell migration |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0061044 | Biological process | negative regulation of vascular wound healing |
GO_1904706 | Biological process | negative regulation of vascular associated smooth muscle cell proliferation |
GO_0005615 | Cellular component | extracellular space |
GO_0005737 | Cellular component | cytoplasm |
GO_0005125 | Molecular function | cytokine activity |
GO_0048018 | Molecular function | receptor ligand activity |
GO_0001664 | Molecular function | G protein-coupled receptor binding |
Gene name | TAFA5 |
Protein name | TAFA chemokine like family member 5 Chemokine-like protein TAFA-5 |
Synonyms | UNQ5208/PRO34524 FAM19A5 |
Description | FUNCTION: Acts as a chemokine-like protein by regulating cell proliferation and migration through activation of G protein-coupled receptors (GPCRs), such as S1PR2 and FPR2 (By similarity). Stimulates chemotactic migration of macrophages mediated by the MAPK3/ERK1 and AKT1 pathway (By similarity). Blocks TNFSF11/RANKL-induced osteoclast formation from macrophages by inhibiting up-regulation of osteoclast fusogenic and differentiation genes (By similarity). Stimulation of macrophage migration and inhibition of osteoclast formation is mediated via GPCR FPR2 (By similarity). Acts as an adipokine by negatively regulating vascular smooth muscle cell (VSMC) proliferation and migration in response to platelet-derived growth factor stimulation via GPCR S1PR2 and G protein GNA12/GNA13-transmitted RHOA signaling (By similarity). Inhibits injury-induced cell proliferation and neointima formation in the femoral arteries (By similarity). . |
Accessions | ENST00000402357.6 [Q7Z5A7-1] ENST00000406880.1 [Q7Z5A7-3] Q7Z5A7 ENST00000358295.9 [Q7Z5A7-2] ENST00000336769.9 B1B1J6 |